HK1104790A1 - Pharmaceutical formulations of fenofibrate having improved bioavailability - Google Patents
Pharmaceutical formulations of fenofibrate having improved bioavailabilityInfo
- Publication number
- HK1104790A1 HK1104790A1 HK07113177.1A HK07113177A HK1104790A1 HK 1104790 A1 HK1104790 A1 HK 1104790A1 HK 07113177 A HK07113177 A HK 07113177A HK 1104790 A1 HK1104790 A1 HK 1104790A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fenofibrate
- pharmaceutical formulations
- improved bioavailability
- polethylene
- polyethylene glycol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05258082A EP1803441B1 (en) | 2005-12-28 | 2005-12-28 | Pharmaceutical formulations of fenofibrate having improved bioavailability |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1104790A1 true HK1104790A1 (en) | 2008-01-25 |
Family
ID=36260529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07113177.1A HK1104790A1 (en) | 2005-12-28 | 2007-12-03 | Pharmaceutical formulations of fenofibrate having improved bioavailability |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1803441B1 (xx) |
AT (1) | ATE429902T1 (xx) |
DE (1) | DE602005014258D1 (xx) |
DK (1) | DK1803441T3 (xx) |
ES (1) | ES2325450T3 (xx) |
HK (1) | HK1104790A1 (xx) |
PL (1) | PL1803441T3 (xx) |
PT (1) | PT1803441E (xx) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627696B1 (fr) | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
FR2730231B1 (fr) | 1995-02-02 | 1997-04-04 | Fournier Sca Lab | Association de fenofibrate et de vitamine e, utilisation en therapeutique |
FR2737121B1 (fr) | 1995-07-27 | 1997-10-03 | Cl Pharma | Nouvelles formulations galeniques du fenofibrate et leurs applications |
FR2758459B1 (fr) | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6814977B1 (en) | 1998-12-18 | 2004-11-09 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6368622B2 (en) * | 1999-01-29 | 2002-04-09 | Abbott Laboratories | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
US6719999B2 (en) | 1999-03-31 | 2004-04-13 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
AU6294501A (en) * | 2000-09-20 | 2002-04-02 | Rtp Pharma Inc | Spray drying process and compositions of fenofibrate |
US7276249B2 (en) | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
EP2087882A1 (en) | 2002-03-26 | 2009-08-12 | Teva Pharmaceutical Industries Ltd. | Drug microparticles |
US7658944B2 (en) * | 2003-10-10 | 2010-02-09 | Lifecycle Pharma A/S | Solid dosage form comprising a fibrate |
-
2005
- 2005-12-28 ES ES05258082T patent/ES2325450T3/es active Active
- 2005-12-28 EP EP05258082A patent/EP1803441B1/en active Active
- 2005-12-28 PL PL05258082T patent/PL1803441T3/pl unknown
- 2005-12-28 PT PT05258082T patent/PT1803441E/pt unknown
- 2005-12-28 DE DE602005014258T patent/DE602005014258D1/de active Active
- 2005-12-28 DK DK05258082T patent/DK1803441T3/da active
- 2005-12-28 AT AT05258082T patent/ATE429902T1/de not_active IP Right Cessation
-
2007
- 2007-12-03 HK HK07113177.1A patent/HK1104790A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK1803441T3 (da) | 2009-08-03 |
ES2325450T3 (es) | 2009-09-04 |
EP1803441B1 (en) | 2009-04-29 |
PL1803441T3 (pl) | 2009-10-30 |
DE602005014258D1 (de) | 2009-06-10 |
PT1803441E (pt) | 2009-06-08 |
ATE429902T1 (de) | 2009-05-15 |
EP1803441A1 (en) | 2007-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005020913A3 (en) | Formulations, conjugates, and combinations of drugs for the treatment of neoplasms | |
WO2006128692A3 (en) | 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system | |
PL1809329T3 (pl) | Kompozycja znieczulająca zawierająca saib o przedłużonym uwalnianiu do stosowania miejscowego | |
TW200716206A (en) | Unitary pharmaceutical dosage form | |
CL2007003244A1 (es) | Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
MY140739A (en) | 2, 6-quinolinyl derivatives, processes for preparing them and their uses | |
TN2009000093A1 (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
TW200731991A (en) | Lipophilic di(anticancer drug) compounds, compositions and related methods | |
WO2007021970A3 (en) | Stable pharmaceutical formulations and methods of use thereof | |
TWI268278B (en) | 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses | |
WO2006072070A3 (en) | Pharmaceutical formulations of gallium salts | |
TW200718698A (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
NO20064808L (no) | Orale matrixformuleringer med licarbazepin | |
BRPI0520821A2 (pt) | formulações farmacêuticas de fenofibrato com biodisponibilidade melhorada | |
TW200731990A (en) | Lipophilic anticancer drug compounds, compositions, and related methods | |
HRP20080422T3 (en) | Satraplatin for treating resistant or refractory tumors | |
EP1669065A4 (en) | DRUGS WITH (2R) -2-PROPYLOCTANIC ACID AS ACTIVE SUBSTANCE | |
TW200716618A (en) | Chemical compounds | |
WO2004064757A3 (en) | Absorption enhancing agents | |
HK1104790A1 (en) | Pharmaceutical formulations of fenofibrate having improved bioavailability | |
TW200731964A (en) | Pharmaceutical formulations of fenofibrate having improved bioavailability | |
WO2005110363A3 (en) | Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles | |
ZA200501010B (en) | BenzoÄBÜchromeno-naphthyridin-7-one and pyranoÄ2'3':7,8ÜquinoÄ2,3-BÜquinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them. | |
EP1726298A3 (en) | Oral liquid formulations containing citalopram | |
ZA200805656B (en) | Prodrug ER²-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20121228 |